Prevalence of HIV and HBV and associated risk factors in communal areas: programmatic implications in the peripheral areas of Yaounde

  • Kamga Wouambo Rodrigue 1Estuary Academy and Strategic Institute (IUES/INSAM/ISSAS), Higher Institute of Health Applied Sciences, University of Buea, Buea, Cameroon
  • Kagoue Simeni Luc Aimé Estuary Academy and Strategic Institute (IUES/INSAM/ISSAS), Higher Institute of Health Applied Sciences, University of Buea, Buea, Cameroon
  • Tchatchouang Serges Estuary Academy and Strategic Institute (IUES/INSAM/ISSAS), Higher Institute of Health Applied Sciences, University of Buea, Buea, Cameroon
  • Philippe Salomon Nguwoh Faculty of Science, Department of Biochemistry, University of Yaounde 1, Yaounde, Cameroon 6National Public Health Laboratory-Ministry of Public Health, Yaounde, Cameroon
  • Panka Tchinda Gaelle
  • Mbarawa Marat Kofia Ibrahim The Higher Institute of Health Sciences (ISPS), Yaounde, Cameroon
  • Jean-Thierry Ebogo Belobo nstitute of Medical Research and Medicinal Plant Study, Yaounde, Cameroon
  • Lawan Loubou Mohamadou National Radiation Protection Agency, Yaounde, Cameroon
  • Livo F. Esemu The Biotechnology Center, University of Yaounde I, Yaounde, Cameroon
  • Taheu Ngounouh Christian Faculty of medicine and pharmaceutical sciences (FMPS), University of Douala, Douala, Cameroon
  • Fokam Josep Estuary Academy and Strategic Institute (IUES/INSAM/ISSAS), Higher Institute of Health Applied Sciences, University of Buea, Buea, Cameroon
Keywords: Seroprevalence, HIV, HBV, risks factors, communal area.

Abstract

Background:The prevalence of HIV and HBV infections differs from place to place with few evidence on their risk factors. The aim of this study was to evaluate the seroprevalenceand risk factors of HIV, HBV in Ottou village, a communal area on the outskirts of Yaounde. Methods:A cross-sectional study was carried out from May to September 2018 at “Sainte Monique”, a pediatric and gynecologic health centre. Associations between AIDS and HBV knowledge, demographics, behavior factors and blood transfusionand HIV and HBV infection were analyzed using a Chi-square and Odd ratio.Testswas performed using Epi info 7 withp<0.05, as significance.Results: Among 153 enrolled participants, the median age was 29 years old with interquartile range from 22 to 36 years. The prevalence of HIV, HBVand the co- infection HIV/HBV was respectively 11.11% (17/153), 14.37% (22/153) and1.3% (2/153). We found that females were more infected by HIV than men (13.3% vs. 6.3%). Contrariwise, men were more infected by HBV (16.7% vs. 11.4%) however, the differences were not statistically significant, respectively (p= 0.31; p=0.37). Univariate analysis identified that multiple sexual partners (OR 3.35, 95% CI: 1.17-9.61, p=0.019) and the lack of awareness on HBV (OR 5.96, 95% CI: 1.97-18.07, p=0.0001)were associated risk factors to contracting HBV whereas having multiple sexual partners was the only identifiable risk factor for HIV (OR 7.5,95% CI: 1.65-34.06, P=0.0064). Conclusions:Targeted, tailored, and comprehensive interventions are urgently needed to prevent the HIV and HBV infections in this locality.

References

. Matthews PC, Geretti AM, Goulder PJ and
Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J Clin Virol. 2014; 61(1):20- 33.
2. UNAIDS, Global Report: UNAIDS report on the global AIDS epidemic 2013, Geneva,Switzerland,.2013.Availablefrom:http://ww w.unaids.org/en/media/unaids/contentassets/docume nts/epidemiology/2013/gr2013/UNAIDS_Global_R eport_2013_en.pdf.
3. Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P and D'Arminio Monforte A.Multiple viral infections. J Hepatol. 2006; 44 (Suppl 1): S108-13.
4. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, et al. Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV-Infected Individuals: A Cohort Study and Meta-Analysis. Clin Infect Dis. 2009; 48:1763–71.
12. Celine Nguefeu NKENFOU, Japhette Esther KEMBOU Edith Saounde TEMGOUA Appolinaire DJIKENG, Linda Mekue MOUAFO, Elvis Ndukong NDZIE, Irenee DONKAM, Vitorrio COLIZZI and Martin SanouSobzé. Evaluation of ORAQUICK® HIV-1/2 as oral rapid test. Afr. J. Infect. Dis. 2013; 7(2): 27 – 30.
13. WHO. Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO
14. Available:http://sam- techdiagnostics.com/pdfs/HBSag.pdf Diaspot HBsAg One step Hepatitis B Surface Antigen Test Strip Package Insert [en ligne] [consulté le 22/08/2018].
15. WHO. Hepatitis B. Regional office for South East Asia.
16. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for post exposure prophylaxis. MMWR. 2001; 50(RR-11):1-
5. Graham CS, Baden LR, Yu E, et al. Influence of
human immunodeficiency virus infection on the
course of hepatitis C virus infection: a meta- 52.
analysis. Clin Infect Dis. 2001; 33(4): 562-9.
6. Mallet V, Vallet-Pichard A and Pol S. The impact of human immunodeficiency virus on viral hepatitis.
Liver Int. 2011; 31 (Suppl 1): 135-9.
7. African Network for care of children affected by
AIDS (ANECCA): The handbook on paediatric AIDS in Africa. 15 January 2014 assessed from.http://www.fhi.org/en/HIVAIDS/pub/guide/ma ns.html
17. Richard Njouom, Arnaud Fontanet, 2011. Projet ANRS 12289 Epidémiologie des hépatites virales B, C, et delta au Cameroun: analyse des échantillons de l’Enquête Démographique de Santé 2011. Centre Pasteur du Cameroun
18. Comité national de lutte contre le VIH, 2014. Rapport annuel 2014 des activités de lutte contre le VIH/SIDA et les IST au Cameroun, vers une génération sans sida. Mars 2015.
8. Uleanya Nwachinemere Davidson, Nwokoye Ikenna
Chidiebele, Emodi Ifeoma Josephine, Obidike
Egbuna Olakunle, Ikefuna Anthony Nnaemeka, Eze
Jude Chijioke, Ndu Ikenna Kingsley, The
Prevalence Liver Function And Immunologic Status
Of Children With Hiv And Hepatitis B Virus 21.
Coinfection In Enugu, Nigeria, Afr. J. Infect. Dis.
2016; 10(2) :61-68
9. Levy V, Grant RM. Antiretroviral therapy for
Hepatitis B Virus-HIV Co-infected Patients: Promises and Pitfalls. Cl inInfect Dis. 2006; 43:904- 910
10. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL. HIV-1, Hepatitis B Virus, and Risk of Liver-related Mortality in the Multicenter cohort Study (MACS). Lancet. (2002); 360:1921-1926.
11. Available:http://www.msal.gob.ar/sida/images/storie s/5-comunicacion/pdf/2014-07-alere-determine.pdf. Alere DetermineTM HIV-1/2 test[En ligne]. [Consulté le 22/08/ 2018].
20. Jobert Richie Nansseu, Descartes Maxime Mbogning, Gwladys Chavely Monamele, Stive Fokam Tamoh, Hortense Kamga Gonsu, Charles Kouanfack, et al. Sero-epidemiology of human immunodeficiency virus, hepatitis B virus and hepatitis C virus: a cross-sectional survey in a rural setting of the West region of Cameroon. The Pan African Medical Journal. 2017; 28:201.
21. Jean Joel Bigna Jan René Nkeck, Anderson Ngouo, Ulrich Flore Nyaga, Jean Jacques Noubiap. Hepatitis B virus and HIV coinfection among adults residing in Cameroon: A systematic review and meta-analysis of prevalence studies. Infections, Disease and Health. 2018; 23( 3):170–178.
____________________________________________________________________________________________________________________________________________
Rodrigue et al International Journal of Health and Clinical Research, 2019; 2(3):14-20 www.ijhcr.com
19. Mbopi-Keou FX, Kalla GCM, Tchouamani H, Deugoue Kalla C, Mbahe S, Angwafo III F, Ndumbe PM. Effectiveness of mobile units for mass HIV testing in subsaharan Africa: the Cameroon pioneer experience. Health Sc Dis. 2007; 8 (4): 18-
19
International Journal of Health and Clinical Research, 2019;2(3):14-20 e-ISSN: 2590-3241, p-ISSN: 2590-325X ____________________________________________________________________________________________________________________________________________
22. Jean‐Patrick Molu, Marie Chantal Ngonde Essome,
Chavely Gwladys Monamele and Richard Njouom. Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon. BMC Res Notes. 2018. 11:39.
23. Salpini R, Fokam J, Ceccarelli L, Santoro MM, Nanfack A, Sosso SM, et al. High burden of
HBV‐infection and atypical HBV strains among HIV‐infected Cameroonians. Curr HIV Res.
2016;14(2):165–71
24. Zoufaly A, Onyoh EF, Tih PM, Awasom CN, Feldt
T. High prevalence of hepatitis B and syphilis co‐infections among HIV patients initiating
antiretroviral therapy in the north‐west region of
Cameroon. Int J STD AIDS. 2012;23(6):435–8
25. Akosua Adom Agyeman and Richard Ofori‐Asenso, Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta‐analysis.
AIDS Res Ther. 2016; 13:23.
26. Sara A Healy, Sonia Gupta, and Ann J Melvin,
2013: HIV/HBV coinfection in children and antiviral therapy. Expert Rev Anti Infect Ther.2013 11(3): 251–263.
27. CNLS. Rapport de progrès.2010.
28. Laurent C, Bourgeois A, Mpoudi‐Ngole E,
Kouanfack C, Ciaf L, Nkoue N, et al. High rates of
Source of Support:Nil Conflict of Interest: Nil
active hepatitis B and C co‐infections in HIV‐1 infected Cameroonian adults initiating antiretroviral
therapy. HIV Med. 2010;11(1):85–9.
29. Rusine J, Ondoa P, Asiimwe‐Kateera B, Boer KR,
Uwimana JM, Mukabayire O, et al. High seroprevalence of HBV and HCV infection in
HIV‐infected adults in Kigali, Rwanda. PLoS ONE.
2013;8(5):e63303.
30. Kye‐Duodu G, Nortey P, Malm K, Nyarko KM,
Sackey SO, Ofori S, et al. Prevalence of hepatitis B
virus co‐infection among HIV‐seropositive persons
attending antiretroviral clinics in the Eastern Region
of Ghana. Pan Afr Med J. 2016;25(Suppl 1):7.
31. Diwe CK, Okwara EC, Enwere OO, Azike JE,
Nwaimo NC. Sero‐prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a
suburban University Teaching Hospital in
South‐East Nigeria. Pan Afr Med J. 2013;16:7
32. Luetkemeyer A. Hepatitis B and HIV coinfection.
http://www.hivinsite.ucsf.edu/InSite?page=kb‐05‐0 3‐04#S1X. Accessed March 30th; 2016
Published
2019-03-31